Global Parkinson's Disease (PD) Drugs Market Research Report 2024(Status and Outlook)
Report Overview:
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The Global Parkinson's Disease (PD) Drugs Market Size was estimated at USD 5775.68 million in 2023 and is projected to reach USD 7435.48 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Parkinson's Disease (PD) Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson's Disease (PD) Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson's Disease (PD) Drugs market in any manner.
Global Parkinson's Disease (PD) Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Market Segmentation (by Type)
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
Market Segmentation (by Application)
Hospital
Family
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease (PD) Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The Global Parkinson's Disease (PD) Drugs Market Size was estimated at USD 5775.68 million in 2023 and is projected to reach USD 7435.48 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Parkinson's Disease (PD) Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson's Disease (PD) Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson's Disease (PD) Drugs market in any manner.
Global Parkinson's Disease (PD) Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Market Segmentation (by Type)
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
Market Segmentation (by Application)
Hospital
Family
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Parkinson's Disease (PD) Drugs Market
- Overview of the regional outlook of the Parkinson's Disease (PD) Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease (PD) Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Parkinson's Disease (PD) Drugs
1.2 Key Market Segments
1.2.1 Parkinson's Disease (PD) Drugs Segment by Type
1.2.2 Parkinson's Disease (PD) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON'S DISEASE (PD) DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinson's Disease (PD) Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON'S DISEASE (PD) DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2019-2024)
3.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson's Disease (PD) Drugs Sales Sites, Area Served, Product Type
3.6 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
3.6.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE (PD) DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON'S DISEASE (PD) DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2019-2024)
6.3 Global Parkinson's Disease (PD) Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson's Disease (PD) Drugs Price by Type (2019-2024)
7 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease (PD) Drugs Market Sales by Application (2019-2024)
7.3 Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2019-2024)
8 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson's Disease (PD) Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson's Disease (PD) Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson's Disease (PD) Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Basic Information
9.1.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
9.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Market Performance
9.1.4 Boehringer Ingelheim Business Overview
9.1.5 Boehringer Ingelheim Parkinson's Disease (PD) Drugs SWOT Analysis
9.1.6 Boehringer Ingelheim Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Parkinson's Disease (PD) Drugs Basic Information
9.2.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
9.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Parkinson's Disease (PD) Drugs SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Novartis
9.3.1 Novartis Parkinson's Disease (PD) Drugs Basic Information
9.3.2 Novartis Parkinson's Disease (PD) Drugs Product Overview
9.3.3 Novartis Parkinson's Disease (PD) Drugs Product Market Performance
9.3.4 Novartis Parkinson's Disease (PD) Drugs SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Teva Pharmaceutical Industries
9.4.1 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Basic Information
9.4.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
9.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Market Performance
9.4.4 Teva Pharmaceutical Industries Business Overview
9.4.5 Teva Pharmaceutical Industries Recent Developments
9.5 AbbVie
9.5.1 AbbVie Parkinson's Disease (PD) Drugs Basic Information
9.5.2 AbbVie Parkinson's Disease (PD) Drugs Product Overview
9.5.3 AbbVie Parkinson's Disease (PD) Drugs Product Market Performance
9.5.4 AbbVie Business Overview
9.5.5 AbbVie Recent Developments
9.6 Abital Pharma
9.6.1 Abital Pharma Parkinson's Disease (PD) Drugs Basic Information
9.6.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
9.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Product Market Performance
9.6.4 Abital Pharma Business Overview
9.6.5 Abital Pharma Recent Developments
9.7 Addex Therapeutics
9.7.1 Addex Therapeutics Parkinson's Disease (PD) Drugs Basic Information
9.7.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
9.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Market Performance
9.7.4 Addex Therapeutics Business Overview
9.7.5 Addex Therapeutics Recent Developments
9.8 Biogen
9.8.1 Biogen Parkinson's Disease (PD) Drugs Basic Information
9.8.2 Biogen Parkinson's Disease (PD) Drugs Product Overview
9.8.3 Biogen Parkinson's Disease (PD) Drugs Product Market Performance
9.8.4 Biogen Business Overview
9.8.5 Biogen Recent Developments
9.9 Eisai
9.9.1 Eisai Parkinson's Disease (PD) Drugs Basic Information
9.9.2 Eisai Parkinson's Disease (PD) Drugs Product Overview
9.9.3 Eisai Parkinson's Disease (PD) Drugs Product Market Performance
9.9.4 Eisai Business Overview
9.9.5 Eisai Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Parkinson's Disease (PD) Drugs Basic Information
9.10.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
9.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 F. Hoffmann-La Roche
9.11.1 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Basic Information
9.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
9.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Market Performance
9.11.4 F. Hoffmann-La Roche Business Overview
9.11.5 F. Hoffmann-La Roche Recent Developments
9.12 H. Lundbeck
9.12.1 H. Lundbeck Parkinson's Disease (PD) Drugs Basic Information
9.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
9.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Product Market Performance
9.12.4 H. Lundbeck Business Overview
9.12.5 H. Lundbeck Recent Developments
9.13 Impax Laboratories
9.13.1 Impax Laboratories Parkinson's Disease (PD) Drugs Basic Information
9.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
9.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Product Market Performance
9.13.4 Impax Laboratories Business Overview
9.13.5 Impax Laboratories Recent Developments
9.14 Kyowa Hakko Kirin
9.14.1 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Basic Information
9.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
9.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Market Performance
9.14.4 Kyowa Hakko Kirin Business Overview
9.14.5 Kyowa Hakko Kirin Recent Developments
9.15 Otsuka Pharmaceutical
9.15.1 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Basic Information
9.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
9.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Market Performance
9.15.4 Otsuka Pharmaceutical Business Overview
9.15.5 Otsuka Pharmaceutical Recent Developments
9.16 Pfizer
9.16.1 Pfizer Parkinson's Disease (PD) Drugs Basic Information
9.16.2 Pfizer Parkinson's Disease (PD) Drugs Product Overview
9.16.3 Pfizer Parkinson's Disease (PD) Drugs Product Market Performance
9.16.4 Pfizer Business Overview
9.16.5 Pfizer Recent Developments
10 PARKINSON'S DISEASE (PD) DRUGS MARKET FORECAST BY REGION
10.1 Global Parkinson's Disease (PD) Drugs Market Size Forecast
10.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region
10.2.4 South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinson's Disease (PD) Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Parkinson's Disease (PD) Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Type (2025-2030)
11.1.2 Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinson's Disease (PD) Drugs by Type (2025-2030)
11.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Parkinson's Disease (PD) Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Parkinson's Disease (PD) Drugs
1.2 Key Market Segments
1.2.1 Parkinson's Disease (PD) Drugs Segment by Type
1.2.2 Parkinson's Disease (PD) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON'S DISEASE (PD) DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinson's Disease (PD) Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON'S DISEASE (PD) DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2019-2024)
3.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson's Disease (PD) Drugs Sales Sites, Area Served, Product Type
3.6 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
3.6.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE (PD) DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON'S DISEASE (PD) DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2019-2024)
6.3 Global Parkinson's Disease (PD) Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson's Disease (PD) Drugs Price by Type (2019-2024)
7 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease (PD) Drugs Market Sales by Application (2019-2024)
7.3 Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2019-2024)
8 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson's Disease (PD) Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson's Disease (PD) Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson's Disease (PD) Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Basic Information
9.1.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
9.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Market Performance
9.1.4 Boehringer Ingelheim Business Overview
9.1.5 Boehringer Ingelheim Parkinson's Disease (PD) Drugs SWOT Analysis
9.1.6 Boehringer Ingelheim Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Parkinson's Disease (PD) Drugs Basic Information
9.2.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
9.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Parkinson's Disease (PD) Drugs SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Novartis
9.3.1 Novartis Parkinson's Disease (PD) Drugs Basic Information
9.3.2 Novartis Parkinson's Disease (PD) Drugs Product Overview
9.3.3 Novartis Parkinson's Disease (PD) Drugs Product Market Performance
9.3.4 Novartis Parkinson's Disease (PD) Drugs SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Teva Pharmaceutical Industries
9.4.1 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Basic Information
9.4.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
9.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Market Performance
9.4.4 Teva Pharmaceutical Industries Business Overview
9.4.5 Teva Pharmaceutical Industries Recent Developments
9.5 AbbVie
9.5.1 AbbVie Parkinson's Disease (PD) Drugs Basic Information
9.5.2 AbbVie Parkinson's Disease (PD) Drugs Product Overview
9.5.3 AbbVie Parkinson's Disease (PD) Drugs Product Market Performance
9.5.4 AbbVie Business Overview
9.5.5 AbbVie Recent Developments
9.6 Abital Pharma
9.6.1 Abital Pharma Parkinson's Disease (PD) Drugs Basic Information
9.6.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
9.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Product Market Performance
9.6.4 Abital Pharma Business Overview
9.6.5 Abital Pharma Recent Developments
9.7 Addex Therapeutics
9.7.1 Addex Therapeutics Parkinson's Disease (PD) Drugs Basic Information
9.7.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
9.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Market Performance
9.7.4 Addex Therapeutics Business Overview
9.7.5 Addex Therapeutics Recent Developments
9.8 Biogen
9.8.1 Biogen Parkinson's Disease (PD) Drugs Basic Information
9.8.2 Biogen Parkinson's Disease (PD) Drugs Product Overview
9.8.3 Biogen Parkinson's Disease (PD) Drugs Product Market Performance
9.8.4 Biogen Business Overview
9.8.5 Biogen Recent Developments
9.9 Eisai
9.9.1 Eisai Parkinson's Disease (PD) Drugs Basic Information
9.9.2 Eisai Parkinson's Disease (PD) Drugs Product Overview
9.9.3 Eisai Parkinson's Disease (PD) Drugs Product Market Performance
9.9.4 Eisai Business Overview
9.9.5 Eisai Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Parkinson's Disease (PD) Drugs Basic Information
9.10.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
9.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 F. Hoffmann-La Roche
9.11.1 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Basic Information
9.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
9.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Market Performance
9.11.4 F. Hoffmann-La Roche Business Overview
9.11.5 F. Hoffmann-La Roche Recent Developments
9.12 H. Lundbeck
9.12.1 H. Lundbeck Parkinson's Disease (PD) Drugs Basic Information
9.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
9.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Product Market Performance
9.12.4 H. Lundbeck Business Overview
9.12.5 H. Lundbeck Recent Developments
9.13 Impax Laboratories
9.13.1 Impax Laboratories Parkinson's Disease (PD) Drugs Basic Information
9.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
9.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Product Market Performance
9.13.4 Impax Laboratories Business Overview
9.13.5 Impax Laboratories Recent Developments
9.14 Kyowa Hakko Kirin
9.14.1 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Basic Information
9.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
9.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Market Performance
9.14.4 Kyowa Hakko Kirin Business Overview
9.14.5 Kyowa Hakko Kirin Recent Developments
9.15 Otsuka Pharmaceutical
9.15.1 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Basic Information
9.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
9.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Market Performance
9.15.4 Otsuka Pharmaceutical Business Overview
9.15.5 Otsuka Pharmaceutical Recent Developments
9.16 Pfizer
9.16.1 Pfizer Parkinson's Disease (PD) Drugs Basic Information
9.16.2 Pfizer Parkinson's Disease (PD) Drugs Product Overview
9.16.3 Pfizer Parkinson's Disease (PD) Drugs Product Market Performance
9.16.4 Pfizer Business Overview
9.16.5 Pfizer Recent Developments
10 PARKINSON'S DISEASE (PD) DRUGS MARKET FORECAST BY REGION
10.1 Global Parkinson's Disease (PD) Drugs Market Size Forecast
10.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region
10.2.4 South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinson's Disease (PD) Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Parkinson's Disease (PD) Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Type (2025-2030)
11.1.2 Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinson's Disease (PD) Drugs by Type (2025-2030)
11.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Parkinson's Disease (PD) Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson's Disease (PD) Drugs Market Size Comparison by Region (M USD)
Table 5. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson's Disease (PD) Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2022)
Table 10. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson's Disease (PD) Drugs Sales Sites and Area Served
Table 12. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 13. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson's Disease (PD) Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease (PD) Drugs Market Challenges
Table 22. Global Parkinson's Disease (PD) Drugs Sales by Type (Kilotons)
Table 23. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 24. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson's Disease (PD) Drugs Market Size Share by Type (2019-2024)
Table 28. Global Parkinson's Disease (PD) Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) by Application
Table 30. Global Parkinson's Disease (PD) Drugs Market Size by Application
Table 31. Global Parkinson's Disease (PD) Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson's Disease (PD) Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson's Disease (PD) Drugs Market Share by Application (2019-2024)
Table 35. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson's Disease (PD) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson's Disease (PD) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Parkinson's Disease (PD) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Parkinson's Disease (PD) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Basic Information
Table 44. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
Table 45. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Boehringer Ingelheim Business Overview
Table 47. Boehringer Ingelheim Parkinson's Disease (PD) Drugs SWOT Analysis
Table 48. Boehringer Ingelheim Recent Developments
Table 49. GlaxoSmithKline Parkinson's Disease (PD) Drugs Basic Information
Table 50. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
Table 51. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Parkinson's Disease (PD) Drugs SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Novartis Parkinson's Disease (PD) Drugs Basic Information
Table 56. Novartis Parkinson's Disease (PD) Drugs Product Overview
Table 57. Novartis Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis Parkinson's Disease (PD) Drugs SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Basic Information
Table 62. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
Table 63. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Teva Pharmaceutical Industries Business Overview
Table 65. Teva Pharmaceutical Industries Recent Developments
Table 66. AbbVie Parkinson's Disease (PD) Drugs Basic Information
Table 67. AbbVie Parkinson's Disease (PD) Drugs Product Overview
Table 68. AbbVie Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AbbVie Business Overview
Table 70. AbbVie Recent Developments
Table 71. Abital Pharma Parkinson's Disease (PD) Drugs Basic Information
Table 72. Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
Table 73. Abital Pharma Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Abital Pharma Business Overview
Table 75. Abital Pharma Recent Developments
Table 76. Addex Therapeutics Parkinson's Disease (PD) Drugs Basic Information
Table 77. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
Table 78. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Addex Therapeutics Business Overview
Table 80. Addex Therapeutics Recent Developments
Table 81. Biogen Parkinson's Disease (PD) Drugs Basic Information
Table 82. Biogen Parkinson's Disease (PD) Drugs Product Overview
Table 83. Biogen Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Biogen Business Overview
Table 85. Biogen Recent Developments
Table 86. Eisai Parkinson's Disease (PD) Drugs Basic Information
Table 87. Eisai Parkinson's Disease (PD) Drugs Product Overview
Table 88. Eisai Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Eisai Business Overview
Table 90. Eisai Recent Developments
Table 91. Eli Lilly Parkinson's Disease (PD) Drugs Basic Information
Table 92. Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
Table 93. Eli Lilly Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Recent Developments
Table 96. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Basic Information
Table 97. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
Table 98. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. F. Hoffmann-La Roche Business Overview
Table 100. F. Hoffmann-La Roche Recent Developments
Table 101. H. Lundbeck Parkinson's Disease (PD) Drugs Basic Information
Table 102. H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
Table 103. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. H. Lundbeck Business Overview
Table 105. H. Lundbeck Recent Developments
Table 106. Impax Laboratories Parkinson's Disease (PD) Drugs Basic Information
Table 107. Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
Table 108. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Impax Laboratories Business Overview
Table 110. Impax Laboratories Recent Developments
Table 111. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Basic Information
Table 112. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
Table 113. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Kyowa Hakko Kirin Business Overview
Table 115. Kyowa Hakko Kirin Recent Developments
Table 116. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Basic Information
Table 117. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
Table 118. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Otsuka Pharmaceutical Business Overview
Table 120. Otsuka Pharmaceutical Recent Developments
Table 121. Pfizer Parkinson's Disease (PD) Drugs Basic Information
Table 122. Pfizer Parkinson's Disease (PD) Drugs Product Overview
Table 123. Pfizer Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Pfizer Business Overview
Table 125. Pfizer Recent Developments
Table 126. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Parkinson's Disease (PD) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Parkinson's Disease (PD) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Parkinson's Disease (PD) Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Parkinson's Disease (PD) Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson's Disease (PD) Drugs Market Size Comparison by Region (M USD)
Table 5. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson's Disease (PD) Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2022)
Table 10. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson's Disease (PD) Drugs Sales Sites and Area Served
Table 12. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 13. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson's Disease (PD) Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease (PD) Drugs Market Challenges
Table 22. Global Parkinson's Disease (PD) Drugs Sales by Type (Kilotons)
Table 23. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 24. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson's Disease (PD) Drugs Market Size Share by Type (2019-2024)
Table 28. Global Parkinson's Disease (PD) Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) by Application
Table 30. Global Parkinson's Disease (PD) Drugs Market Size by Application
Table 31. Global Parkinson's Disease (PD) Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson's Disease (PD) Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson's Disease (PD) Drugs Market Share by Application (2019-2024)
Table 35. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson's Disease (PD) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson's Disease (PD) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Parkinson's Disease (PD) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Parkinson's Disease (PD) Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Basic Information
Table 44. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
Table 45. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Boehringer Ingelheim Business Overview
Table 47. Boehringer Ingelheim Parkinson's Disease (PD) Drugs SWOT Analysis
Table 48. Boehringer Ingelheim Recent Developments
Table 49. GlaxoSmithKline Parkinson's Disease (PD) Drugs Basic Information
Table 50. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
Table 51. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Parkinson's Disease (PD) Drugs SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Novartis Parkinson's Disease (PD) Drugs Basic Information
Table 56. Novartis Parkinson's Disease (PD) Drugs Product Overview
Table 57. Novartis Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis Parkinson's Disease (PD) Drugs SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Basic Information
Table 62. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
Table 63. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Teva Pharmaceutical Industries Business Overview
Table 65. Teva Pharmaceutical Industries Recent Developments
Table 66. AbbVie Parkinson's Disease (PD) Drugs Basic Information
Table 67. AbbVie Parkinson's Disease (PD) Drugs Product Overview
Table 68. AbbVie Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AbbVie Business Overview
Table 70. AbbVie Recent Developments
Table 71. Abital Pharma Parkinson's Disease (PD) Drugs Basic Information
Table 72. Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
Table 73. Abital Pharma Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Abital Pharma Business Overview
Table 75. Abital Pharma Recent Developments
Table 76. Addex Therapeutics Parkinson's Disease (PD) Drugs Basic Information
Table 77. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
Table 78. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Addex Therapeutics Business Overview
Table 80. Addex Therapeutics Recent Developments
Table 81. Biogen Parkinson's Disease (PD) Drugs Basic Information
Table 82. Biogen Parkinson's Disease (PD) Drugs Product Overview
Table 83. Biogen Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Biogen Business Overview
Table 85. Biogen Recent Developments
Table 86. Eisai Parkinson's Disease (PD) Drugs Basic Information
Table 87. Eisai Parkinson's Disease (PD) Drugs Product Overview
Table 88. Eisai Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Eisai Business Overview
Table 90. Eisai Recent Developments
Table 91. Eli Lilly Parkinson's Disease (PD) Drugs Basic Information
Table 92. Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
Table 93. Eli Lilly Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Recent Developments
Table 96. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Basic Information
Table 97. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
Table 98. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. F. Hoffmann-La Roche Business Overview
Table 100. F. Hoffmann-La Roche Recent Developments
Table 101. H. Lundbeck Parkinson's Disease (PD) Drugs Basic Information
Table 102. H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
Table 103. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. H. Lundbeck Business Overview
Table 105. H. Lundbeck Recent Developments
Table 106. Impax Laboratories Parkinson's Disease (PD) Drugs Basic Information
Table 107. Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
Table 108. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Impax Laboratories Business Overview
Table 110. Impax Laboratories Recent Developments
Table 111. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Basic Information
Table 112. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
Table 113. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Kyowa Hakko Kirin Business Overview
Table 115. Kyowa Hakko Kirin Recent Developments
Table 116. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Basic Information
Table 117. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
Table 118. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Otsuka Pharmaceutical Business Overview
Table 120. Otsuka Pharmaceutical Recent Developments
Table 121. Pfizer Parkinson's Disease (PD) Drugs Basic Information
Table 122. Pfizer Parkinson's Disease (PD) Drugs Product Overview
Table 123. Pfizer Parkinson's Disease (PD) Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Pfizer Business Overview
Table 125. Pfizer Recent Developments
Table 126. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Parkinson's Disease (PD) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Parkinson's Disease (PD) Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Parkinson's Disease (PD) Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Parkinson's Disease (PD) Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Parkinson's Disease (PD) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease (PD) Drugs Market Size (M USD), 2019-2030
Figure 5. Global Parkinson's Disease (PD) Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease (PD) Drugs Market Size by Country (M USD)
Figure 11. Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2023
Figure 13. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease (PD) Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson's Disease (PD) Drugs Market Share by Type
Figure 18. Sales Market Share of Parkinson's Disease (PD) Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson's Disease (PD) Drugs by Type in 2023
Figure 20. Market Size Share of Parkinson's Disease (PD) Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson's Disease (PD) Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson's Disease (PD) Drugs Market Share by Application
Figure 24. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2023
Figure 26. Global Parkinson's Disease (PD) Drugs Market Share by Application (2019-2024)
Figure 27. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2023
Figure 28. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Parkinson's Disease (PD) Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson's Disease (PD) Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2023
Figure 37. Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2023
Figure 44. China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Parkinson's Disease (PD) Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Parkinson's Disease (PD) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease (PD) Drugs Market Size (M USD), 2019-2030
Figure 5. Global Parkinson's Disease (PD) Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Parkinson's Disease (PD) Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease (PD) Drugs Market Size by Country (M USD)
Figure 11. Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2023
Figure 13. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease (PD) Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson's Disease (PD) Drugs Market Share by Type
Figure 18. Sales Market Share of Parkinson's Disease (PD) Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson's Disease (PD) Drugs by Type in 2023
Figure 20. Market Size Share of Parkinson's Disease (PD) Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson's Disease (PD) Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson's Disease (PD) Drugs Market Share by Application
Figure 24. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2023
Figure 26. Global Parkinson's Disease (PD) Drugs Market Share by Application (2019-2024)
Figure 27. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2023
Figure 28. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Parkinson's Disease (PD) Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson's Disease (PD) Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2023
Figure 37. Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2023
Figure 44. China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Parkinson's Disease (PD) Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2025-2030)
